{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:25:08Z","timestamp":1793967908207,"version":"4.8.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clinsp.2025.100850","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T19:28:09Z","timestamp":1774034889000},"page":"100850","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Circ-RERE promotes autophagy and immune escape in acute myeloid leukemia involving the miR-128-3p\/ZEB1\/PD-L1 axis"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3752-8317","authenticated-orcid":false,"given":"XiaoWei","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9886-9612","authenticated-orcid":false,"given":"TianTian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0825-6794","authenticated-orcid":false,"given":"KeYa","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2463-4306","authenticated-orcid":false,"given":"ShuangYue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2630-4762","authenticated-orcid":false,"given":"RenZhi","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0204-726X","authenticated-orcid":false,"given":"Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clinsp.2025.100850_bib0001","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1158\/2159-8290.CD-19-1011","article-title":"Advances in the treatment of acute myeloid leukemia: new drugs and new challenges","volume":"10","author":"Short","year":"2020","journal-title":"Cancer Discov"},{"issue":"9","key":"10.1016\/j.clinsp.2025.100850_bib0002","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1200\/JCO.2016.71.2208","article-title":"Genomics of acute myeloid leukemia diagnosis and pathways","volume":"35","author":"Bullinger","year":"2017","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clinsp.2025.100850_bib0003","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/s41375-019-0387-y","article-title":"Data mining for mutation-specific targets in acute myeloid leukemia","volume":"33","author":"Benard","year":"2019","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.clinsp.2025.100850_bib0004","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1007\/s12015-022-10349-5","article-title":"Leukemic stem cell signatures in acute myeloid leukemia- targeting the Guardians with novel approaches","volume":"18","author":"Thakral","year":"2022","journal-title":"Stem Cell Rev Rep"},{"issue":"13","key":"10.1016\/j.clinsp.2025.100850_bib0005","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1080\/10428194.2020.1802450","article-title":"Survivorship in AML \u2012 a landmark analysis on the outcomes of acute myelogenous leukemia patients after maintaining complete remission for at least 3 years","volume":"61","author":"Major","year":"2020","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100850_bib0006","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3892\/ol.2021.13169","article-title":"CD155 and CD112 as possible therapeutic targets of FLT3 inhibitors for acute myeloid leukemia","volume":"23","author":"Kaito","year":"2022","journal-title":"Oncol Lett"},{"key":"10.1016\/j.clinsp.2025.100850_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2022.03.003","article-title":"Epigenetic maintenance strategies after allogeneic stem cell transplantation in acute myeloid leukemia","volume":"109","author":"Yan","year":"2022","journal-title":"Exp Hematol"},{"issue":"7","key":"10.1016\/j.clinsp.2025.100850_bib0008","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nrg.2016.46","article-title":"Lessons from non-canonical splicing","volume":"17","author":"Sibley","year":"2016","journal-title":"Nat Rev Genet"},{"issue":"9","key":"10.1016\/j.clinsp.2025.100850_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003777","article-title":"Cell-type specific features of circular RNA expression","volume":"9","author":"Salzman","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.clinsp.2025.100850_bib0010","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.3389\/fonc.2019.01108","article-title":"Recent progress on circular RNA research in acute myeloid leukemia","volume":"9","author":"Jamal","year":"2019","journal-title":"Front Oncol."},{"key":"10.1016\/j.clinsp.2025.100850_bib0011","doi-asserted-by":"crossref","DOI":"10.3727\/096504018X15412701483326","article-title":"High circ_100053 predicts a poor outcome for chronic myeloid leukemia and is involved in imatinib resistance","author":"Ping","year":"2019","journal-title":"Oncol Res"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100850_bib0012","doi-asserted-by":"crossref","first-page":"7704","DOI":"10.1080\/21655979.2021.1982310","article-title":"Circular RNA circCRKL inhibits the proliferation of acute myeloid leukemia cells via the miR-196a-5p\/miR-196b-5p\/p27 axis","volume":"12","author":"Liu","year":"2021","journal-title":"Bioengineered"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100850_bib0013","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12885-020-6515-2","article-title":"Comprehensive profiling of circular RNA expressions reveals potential diagnostic and prognostic biomarkers in multiple myeloma","volume":"20","author":"Zhou","year":"2020","journal-title":"BMC Cancer"},{"issue":"49","key":"10.1016\/j.clinsp.2025.100850_bib0014","doi-asserted-by":"crossref","first-page":"86625","DOI":"10.18632\/oncotarget.21257","article-title":"Circular RNA expression profiles reveal that hsa_circ_0018289 is up-regulated in cervical cancer and promotes the tumorigenesis","volume":"8","author":"Gao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.clinsp.2025.100850_bib0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13045-015-0112-x","article-title":"Role of microRNA in chronic lymphocytic leukemia onset and progression","volume":"8","author":"Balatti","year":"2015","journal-title":"J Hematol Oncol"},{"issue":"13","key":"10.1016\/j.clinsp.2025.100850_bib0016","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1080\/15384101.2020.1761617","article-title":"Circular RNA ABCB10 promotes non-small cell lung cancer progression by increasing E2F5 expression through sponging miR-584-5p","volume":"19","author":"Ma","year":"2020","journal-title":"Cell Cycle"},{"issue":"8","key":"10.1016\/j.clinsp.2025.100850_bib0017","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3324\/haematol.2013.099515","article-title":"MicroRNA-128-3p is a novel oncomiR targeting PHF6 in T-cell acute lymphoblastic leukemia","volume":"99","author":"Mets","year":"2014","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.clinsp.2025.100850_bib0018","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1111\/jcmm.16539","article-title":"ZEB1 serves as an oncogene in acute myeloid leukaemia via regulating the PTEN\/PI3K\/AKT signalling pathway by combining with P53","volume":"25","author":"Li","year":"2021","journal-title":"J Cell Mol Med"},{"issue":"6","key":"10.1016\/j.clinsp.2025.100850_bib0019","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.7150\/ijbs.70137","article-title":"MGP promotes CD8+ T cell exhaustion by activating the NF-\u03bab pathway leading to liver metastasis of colorectal cancer","volume":"18","author":"Rong","year":"2022","journal-title":"Int J Biol Sci"},{"issue":"6","key":"10.1016\/j.clinsp.2025.100850_bib0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3892\/ijo.2021.5287","article-title":"Epigenetic modifications in acute myeloid leukemia: the emerging role of circular RNAs (Review)","volume":"59","author":"Issah","year":"2021","journal-title":"Int J Oncol"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100850_bib0021","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12943-021-01446-z","article-title":"Circular RNAs in acute myeloid leukemia","volume":"20","author":"Singh","year":"2021","journal-title":"Mol Cancer"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100850_bib0022","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000520446","article-title":"Using circ-ANAPC7 as a novel type of biomarker in the monitoring of acute myeloid leukemia","volume":"145","author":"Shen","year":"2022","journal-title":"Acta Haematol"},{"key":"10.1016\/j.clinsp.2025.100850_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2019.106198","article-title":"CircPAN3 contributes to drug resistance in acute myeloid leukemia through regulation of autophagy","volume":"85","author":"Shang","year":"2019","journal-title":"Leuk Res"},{"issue":"4","key":"10.1016\/j.clinsp.2025.100850_bib0024","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41419-021-03566-2","article-title":"CircSPI1 acts as an oncogene in acute myeloid leukemia through antagonizing SPI1 and interacting with microRNAs","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100850_bib0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41375-021-01350-x","article-title":"Catch me if you can: how AML and its niche escape immunotherapy","volume":"36","author":"Tettamanti","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.clinsp.2025.100850_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinsp.2023.100177","article-title":"Programmed cell death-1 and its ligands: current knowledge and possibilities in immunotherapy","volume":"78","author":"Gutic","year":"2023","journal-title":"Clinics (Sao Paulo)"},{"issue":"3","key":"10.1016\/j.clinsp.2025.100850_bib0027","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.4049\/jimmunol.170.3.1257","article-title":"Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production","volume":"170","author":"Brown","year":"2003","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100850_bib0028","article-title":"PD-L1 regulates cell proliferation and apoptosis in acute myeloid leukemia by activating PI3K-AKT signaling pathway","volume":"12","author":"Wang","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinsp.2025.100850_bib0029","doi-asserted-by":"crossref","DOI":"10.1038\/cddiscovery.2015.8","article-title":"Autophagy limits proliferation and glycolytic metabolism in acute myeloid leukemia","volume":"1","author":"Watson","year":"2015","journal-title":"Cell Death Discov"},{"issue":"9","key":"10.1016\/j.clinsp.2025.100850_bib0030","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1182\/blood-2016-01-692244","article-title":"Atg7 suppression enhances chemotherapeutic agent sensitivity and overcomes stroma-mediated chemoresistance in acute myeloid leukemia","volume":"128","author":"Piya","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.clinsp.2025.100850_bib0031","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1084\/jem.20101145","article-title":"The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance","volume":"208","author":"Mortensen","year":"2011","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.clinsp.2025.100850_bib0032","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/15548627.2017.1287652","article-title":"Autophagy is dispensable for Kmt2a\/Mll-Mllt3\/Af9 AML maintenance and anti-leukemic effect of chloroquine","volume":"13","author":"Chen","year":"2017","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100850_bib0033","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12943-017-0663-2","article-title":"CircRNA: functions and properties of a novel potential biomarker for cancer","volume":"16","author":"Meng","year":"2017","journal-title":"Mol Cancer"},{"key":"10.1016\/j.clinsp.2025.100850_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2021.101534","article-title":"MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells","volume":"72","author":"Shi","year":"2021","journal-title":"Tissue Cell"},{"key":"10.1016\/j.clinsp.2025.100850_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108947","article-title":"MiR-128-3p suppresses breast cancer cellular progression via targeting LIMK1","volume":"115","author":"Zhao","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100850_bib0036","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12967-020-02240-z","article-title":"Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer","volume":"18","author":"Wu","year":"2020","journal-title":"J Transl Med"},{"issue":"11","key":"10.1016\/j.clinsp.2025.100850_bib0037","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1007\/s11010-021-04226-x","article-title":"Oncogenic functions of ZEB1 in pediatric solid cancers: interplays with microRNAs and long noncoding RNAs","volume":"476","author":"Fratini","year":"2021","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100850_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113044","article-title":"ZEB1 induces ROS generation through directly promoting MCT4 transcription to facilitate breast cancer","volume":"412","author":"Han","year":"2022","journal-title":"Exp Cell Res"},{"issue":"5","key":"10.1016\/j.clinsp.2025.100850_bib0039","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41419-022-04935-1","article-title":"Cancer associated fibroblast-derived CCL5 promotes hepatocellular carcinoma metastasis through activating HIF1\u03b1\/ZEB1 axis","volume":"13","author":"Xu","year":"2022","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100850_bib0040","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1263412","article-title":"The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200","volume":"6","author":"Noman","year":"2017","journal-title":"Oncoimmunology"},{"issue":"10","key":"10.1016\/j.clinsp.2025.100850_bib0041","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41419-019-1886-5","article-title":"LncRNA SNHG14\/miR-5590-3p\/ZEB1 positive feedback loop promoted diffuse large B cell lymphoma progression and immune evasion through regulating PD-1\/PD-L1 checkpoint","volume":"10","author":"Zhao","year":"2019","journal-title":"Cell Death Dis"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593225002686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593225002686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:31:02Z","timestamp":1793964662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593225002686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":41,"alternative-id":["S1807593225002686"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2025.100850","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circ-RERE promotes autophagy and immune escape in acute myeloid leukemia involving the miR-128-3p\/ZEB1\/PD-L1 axis","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2025.100850","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of HCFMUSP.","name":"copyright","label":"Copyright"}],"article-number":"100850"}}